Shares of protein discovery platform Absci pop in market debut

Absci Corp., a Vancouver company behind a multi-faceted drug development platform, went public on Thursday. It’s another sign of snowballing interest in new approaches to drug development – a traditionally risky business.  Absci focuses on speeding drug development in the preclinical stages. Th…

Source :
Disclaimer: Short summery, auto-generated by bot, is from article's description and not meant to replace reading the original article.
We do not promote or affiliated with external links in any way.
We have no control over the nature, content and availability of those sites.
All content on this site is meant to be used for information purposes only,
should not be taken as investment advice.
Trademarks and related content are owned by their respective companies.
Read the Terms of Services
Do NOT follow this link or you will be banned from the site!